Arylazide photoaffinity probe for alpha 2-adrenoceptors

Area of Science:

• Pharmacology
• Biochemistry
• Molecular Biology

Background:

• Alpha 2-adrenoceptors are critical G protein-coupled receptors involved in various physiological processes.
• Understanding the precise structure and function of alpha 2-adrenoceptors is essential for developing targeted therapeutics.

Purpose of the Study:

• To develop and characterize a novel arylazide photoaffinity probe for alpha 2-adrenoceptors.
• To investigate the irreversible blockade of alpha 2-adrenoceptors using the developed probe.

Main Methods:

• Synthesis and characterization of the arylazide photoaffinity probe, 3-methyl-6-chloro-9-azido-1H-2,3,4,5-tetrahydro-3-benzazepine (SKF 102229).
• Assessment of SKF 102229's binding affinity (Ki) for human platelet alpha 2-adrenoceptors.
• Photolysis of SKF 102229 with ultraviolet light to induce irreversible receptor blockade.
• Evaluation of [3H]yohimbine binding to assess the extent and characteristics of receptor blockade.

Main Results:

• SKF 102229 demonstrated a high affinity (Ki ≈ 40 nM) for human platelet alpha 2-adrenoceptors.
• UV-induced photolysis of SKF 102229 resulted in irreversible blockade of [3H]yohimbine binding.
• The blockade was concentration- and time-dependent, with typically 60% blockade achieved under specific conditions (100 nM SKF 102229, 8 min photolysis).
• Pharmacological characterization confirmed the blockade was specific to alpha 2-adrenoceptors, being sensitive to phentolamine and p-aminoclonidine but not prazosin.

Conclusions:

• SKF 102229 is a potent and specific photoaffinity probe for alpha 2-adrenoceptors.
• The probe enables irreversible blockade of the receptor's ligand binding site.
• SKF 102229 is a valuable tool for future studies on alpha 2-adrenoceptor structure and function.